Primary Site >> Biliary tract Cancer
Gene >> CYP2A6
| 1. | |||||||||||
| Journal: | Br J Cancer. 2011 Feb 15;104(4):605-12. | ||||||||||
| Title: | Phase II study of S-1 combined with oxaliplatin as therapy for patients with metastatic biliary tract cancer: influence of the CYP2A6 polymorphism on pharmacokinetics and clinical activity. | ||||||||||
| Author: | Kim, K-p|Jang, G|Hong, Y S|Lim, H-S|Bae, K-s|Kim, H-S|Lee, S S|Shin, J-G|Lee, J-L|Ryu, M-H|Chang, H-M|Kang, Y-K|Kim, T W | ||||||||||
| PMID: | 21326246 | ||||||||||
| 2. | |||||||||||
| Journal: | Parasitol Int. 2012 Mar;61(1):162-6. | ||||||||||
| Title: | Hepatic cytochrome P450 2A6 and 2E1 status in peri-tumor tissues of patients with Opisthorchis viverrini-associated cholangiocarcinoma. | ||||||||||
| Author: | Yongvanit, Puangrat|Phanomsri, Emorn|Namwat, Nisana|Kampan, Jureeporn|Tassaneeyakul, Wichittra|Loilome, Watcharin|Puapairoj, Anucha|Khuntikeo, Narong | ||||||||||
| PMID: | 21745589 | ||||||||||